IESE (España)
-
Vienna Neubau GmbH (A): CEO and Shareholder
Baselga, Antonio; Stein, Guido; Roure, JuanCase E-129-ELeadership and People ManagementNeubau Vienna GmbH (VN) is a mid-sized company and leading distributor of wood derivatives in the Austrian market. CEO Walter Anzenbruger had decided to hire a general manager who could help steer the company in its new stage. Walter finally decided on Hans Macher, 34, an industrial engineer with an MBA and current director of the Price Waterhouse Office in Graz. He thought that Hans was pulling very heavily on some of his strengths in the negot...Starting at €8.20
-
A Walk Through the United States
Bardolet Urgellès, David; Baucells Alibés, Manel; Ariño, Miguel AngelCase AD-374-EDecision Analysis, EconomicsThe case presents the well-known traveling salesman problem in the context of having to visit 48 U.S. State Capitals.Starting at €8.20
-
Vienna Neubau GmbH (B): Candidate for General Manager
Baselga, Antonio; Stein, Guido; Roure, JuanCase E-130-ELeadership and People ManagementAt age 34, Hans Macher had enjoyed a successful career in one of the world's best-known consulting firms. In November 2008, he received a call from his friend Michael Prosl, a professor at one of Austria's top business schools, who told him about the possibility of joining Vienna Neubau as general manager. His prospects at his current company had been looking less bright recently and there was even some doubt about his position in Graz. Hans knew...Starting at €5.74
-
Un paseo por Estados Unidos
Bardolet Urgellès, David; Baucells Alibés, Manel; Ariño, Miguel AngelCase AD-374Decision Analysis, EconomicsEl caso presenta el bien conocido problema del representante en el contexto de visitar 48 ciudades de Estados Unidos.Starting at €8.20
-
Glaxo: The acquisition of Wellcome
Canals, Jordi; Bardolet Urgellès, DavidCase ASE-386-EEconomicsThis case describes the changes in the world pharmaceutical industry in 1995 and presents the challenges for Glaxo (the leading European pharmaceutical firm) and the potential acquisition of Wellcome. This decision will differ from other acquisitions made by firms like Merck, oriented towards vertical integration and control over the distribution network. The main topics that the case covers are: industry analysis; value chain analysis; positioni...Starting at €8.20